BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Dr. Rana McKay
an antagonist, you know, every day over an agonist just to do everything that I possibly can to mitigate their cardiovascular risk, like whether it be a thrombotic event or arrhythmia or something. So, you know, I think at the end of the day, I think there's probably a little bit more hype than true data. And I think the data that is out there has some flaws in it.
0
💬
0
Comments
Log in to comment.
There are no comments yet.